Table 1.
Baseline characteristics.
| Control group | Calcitriol group | p-Value | |
|---|---|---|---|
| Demographics | 25 | 25 | |
| Age (y) | 64 ± 16 | 69 ± 18 | 0.16 |
| Above age 65 | 19 | 14 | 0.14 |
| Male gender | 13 | 12 | 0.77 |
| Race | 0.90 | ||
| Caucasian | 5 | 7 | |
| Non-White Latino | 15 | 14 | |
| Black | 3 | 2 | |
| Asian | 2 | 2 | |
| Poor prognostic factors | |||
| Body mass index (kg/m2) | 27.2 ± 5 | 27.3 ± 6 | 0.48 |
| BMI > 30 kg/m2 | 6 | 4 | 0.48 |
| Hypertension | 17 | 13 | 0.24 |
| Type 2 diabetes | 11 | 9 | 0.56 |
| Cancer history | 1 | 1 | 1.00 |
| Asthma/COPD | 3 | 5 | 0.44 |
| Admission levels | |||
| Procalcitonin | 0.21 ± 0.27 | 0.11 ± 0.1 | 0.14 |
| IL-6 | 65 ± 114 | 38 ± 27 | 0.29 |
| Lymphocytes (absolute number) | 1.25 ± 0.68 | 1.14 ± 0.55 | 0.51 |
| C-reactive protein | 160.7 ± 381 | 78.9 ± 76.8 | 0.33 |
| Ferritin | 570 ± 667.2 | 902.6 ± 981.8 | 0.18 |
| d-Dimer | 1.36 ± 0.91 | 1.65 ± 2.08 | 0.55 |
| Glomerular filtration rate | 75 ± 41 | 69 ± 23 | 0.28 |
| Oxygen requirements on admission | 0.74 | ||
| Room air | 13 | 11 | |
| Nasal canula | 8 | 12 | |
| High flow nasal canula | 1 | 0 | |
| Non-rebreather | 3 | 1 | |
| Bipap | 0 | 1 | |
| Treatments during admission | |||
| Remdesivir | 11 | 15 | 0.25 |
| Dexamethasone | 12 | 13 | 0.78 |
| Convalescent plasma | 2 | 4 | 0.38 |
| Medical center | 0.67 | ||
| MS Beth Israel | 13 | 15 | |
| MS Morningside | 10 | 7 | |
| MS West | 2 | 3 |